Detalhe da pesquisa
1.
European quality indicators developed by the European Commission Initiative on Breast Cancer: a first nationwide assessment for the Dutch setting.
Breast Cancer Res Treat
; 203(3): 523-531, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37882921
2.
The prognostic role of classical and nonclassical MHC class I expression in endometrial cancer.
Int J Cancer
; 126(6): 1417-27, 2010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19728333
3.
Validation and Modification of a Prediction Model for Acute Cardiac Events in Patients With Breast Cancer Treated With Radiotherapy Based on Three-Dimensional Dose Distributions to Cardiac Substructures.
J Clin Oncol
; 35(11): 1171-1178, 2017 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-28095159
4.
Five year outcomes of hypofractionated simultaneous integrated boost irradiation in breast conserving therapy; patterns of recurrence.
Radiother Oncol
; 108(2): 269-72, 2013 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24055289
5.
Simultaneous integrated boost irradiation after breast-conserving surgery: physician-rated toxicity and cosmetic outcome at 30 months' follow-up.
Int J Radiat Oncol Biol Phys
; 83(4): e471-7, 2012 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22494592
6.
Early-stage young breast cancer patients: impact of local treatment on survival.
Int J Radiat Oncol Biol Phys
; 81(4): e553-9, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21601378
7.
Three-dimensional conformal hypofractionated simultaneous integrated boost in breast conserving therapy: results on local control and survival.
Radiother Oncol
; 100(2): 215-20, 2011 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-21640422